This was supposed to be the season Chelsea finally found a way to beat Barcelona. Each year they have gotten closer to the ...

The new service has been designed to improve access to some treatments and reduce the need for GP appointments ...

Your cosmetics might not be as harmless as you think if you're not paying attention to a small clue on the packaging.... Here ...

Early treatment with Ocrevus may help protect the cerebellum from damage in people with multiple sclerosis, a study found.

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Researchers studied 118 SMA type 2 patients and saw their RULM scores stayed higher than expected had their disease kept its ...

Treatment with regulatory T-cells, known as Tregs, was well tolerated and seemed to reduce disease activity in a small ...

ICON Public Limited Company’s ICLR share price has surged by 5.63%, which has investors questioning if this is right time to sell.

Europe follows with USD 1.2 billion, supported by regulatory mandates and strong clinical research institutions. US, NY, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- Global Cardiac Safety ...

Don’t waste another minute; get started by clicking here here.(Sponsor) ICON (NASDAQ:ICLR) is a research company that specializes in clinical trials. It is a profitable company that has been on a ...

Vaccinex (VCNX) will present exciting new data characterizing the unique mechanism of pepinemab to enhance immune responses to checkpoint ...